Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 35Breast Neoplasms 8Obesity 5Neoplasms 5Prostatic Neoplasms 4Insulin Resistance 4Pancreatic Neoplasms 3Infertility 3Endometrial Neoplasms 3Diabetes Mellitus 3Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Mouth Neoplasms 2Metabolic Syndrome 2Liver Neoplasms 2Hyperandrogenism 2Diabetes, Gestational 2Diabetes Mellitus, Type 2 2Depression 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Anovulation 2Weight Loss 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Testosterone 1Metformin 1Gonadotropin-Releasing Hormone 1Canagliflozin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Non-alcoholic Fatty Liver Disease × Metformin × Clear all
NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

The First Affiliated Hospital of Shanxi Medical University

Phase 4 Unknown
50 enrolled

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡